Morgan Stanley’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.05K | Sell |
|
|||||
|
2025
Q1 | $6.64K | Buy |
|
|||||
|
2024
Q4 | $16.9K | Sell |
|
|||||
|
2024
Q3 | $106K | Buy |
|
|||||
|
2024
Q2 | $39K | Sell |
|
|||||
|
2024
Q1 | $326K | Sell |
|
|||||
|
2023
Q4 | $748K | Buy |
|
|||||
|
2023
Q3 | $320K | Sell |
|
|||||
|
2023
Q2 | $416K | Buy |
|
|||||
|
2023
Q1 | $228K | Buy |
|
|||||
|
2022
Q4 | $149K | Sell |
|
|||||
|
2022
Q3 | $243K | Buy |
|
|||||
|
2022
Q2 | $323K | Sell |
|
|||||
|
2022
Q1 | $464K | Buy |
|
|||||
|
2021
Q4 | $531K | Buy |
|
|||||
|
2021
Q3 | $660K | Buy |
|
|||||
|
2021
Q2 | $637K | Sell |
|
|||||
|
2021
Q1 | $1.11M | Sell |
|
|||||
|
2020
Q4 | $1.84M | Sell |
|
|||||
|
2020
Q3 | $1.26M | Buy |
|
|||||
|
2020
Q2 | $966K | Buy |
|
|||||
|
2020
Q1 | $457K | Buy |
|
|||||
|
2019
Q4 | $576K | Buy |
|
|||||
|
2019
Q3 | $384K | Buy |
|
|||||
|
2019
Q2 | $519K | Buy |
|
|||||
|
2019
Q1 | $406K | Sell |
|
|||||
|
2018
Q4 | $430K | Buy |
|
|||||
|
2018
Q3 | $1.03M | Sell |
|
|||||
|
2018
Q2 | $900K | Sell |
|
|||||
|
2018
Q1 | $981K | Buy |
|
|||||
|
2017
Q4 | $1.14M | Buy |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $680K | Buy |
|
|||||
|
2017
Q1 | $737K | Buy |
|
|||||
|
2016
Q4 | $567K | Buy |
|
|||||
|
2016
Q3 | $634K | Buy |
|
|||||
|
2016
Q2 | $387K | Buy |
|
|||||
|
2016
Q1 | $441K | Sell |
|
|||||
|
2015
Q4 | $594K | Sell |
|
|||||
|
2015
Q3 | $812K | Sell |
|
|||||
|
2015
Q2 | $1.46M | Buy |
|
|||||
|
2015
Q1 | $725K | Buy |
|
|||||
|
2014
Q4 | $44K | Buy |
|
|||||
|
2014
Q3 | $16K | Hold |
|
|||||
|
2014
Q2 | $21K | Buy |
|
|||||
|
2014
Q1 | $21K | Buy |
|